Laparoscopic Nissen Versus Anterior Partial Fundoplication

NCT ID: NCT01669330

Last Updated: 2014-04-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2001-01-31

Study Completion Date

2014-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The most widely used operative technique for gastroesophageal reflux is total fundoplication where the gastric fundus is sutured around the distal esophagus like a wrap. This operation effectively prevents gastroesophageal reflux but gives rise to postoperative symptoms related to over-competence of the gastroesophageal junction. 40% of the operated patients experience increased flatulence and 20% dysphagia. Anterior fundoplication is an alternative technique where the distal esophagus is anchored to the crura of the hiatus esophagi and only a part of the front wall of the esophagus is covered with fundus. An anterior fundoplication is un attempt to create a more physiologic reflux control and less functional problems postoperatively. The aim with this study is to compare the results postoperatively, both short time and long time results.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Aim: To establish if there is a difference in the incidence of postoperative flatulence after the two different operative techniques. The secondary aims are to establish differences in relapse of reflux, incidence of postoperative dysphagia, dyspepsia, quality of life, hospital stay, sick-leave and complications.

Method: All patients operated on for reflux disease in Lund, Malmö,Trollättan and Kalmar are randomised between the two operations. Postoperatively, telephone interview is performed weekly the first two months. One year and ten years postoperatively. The patients are investigated with endoscopy, esophageal manometry, 24 hour pH-monitoring and symptom evaluation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastroesophageal Reflux

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Total fundoplication

Procedure: Laparoscopic Nissen fundoplication

Group Type ACTIVE_COMPARATOR

Nissen fundoplication

Intervention Type PROCEDURE

Laparoscopic Nissen fundoplication

Anterior partial fundoplication

Procedure: Laparoscopic anterior partial fundoplication

Group Type ACTIVE_COMPARATOR

Laparoscopic antireflux surgery ad modum Watson

Intervention Type PROCEDURE

Laparoscopic anterior fundoplication

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nissen fundoplication

Laparoscopic Nissen fundoplication

Intervention Type PROCEDURE

Laparoscopic antireflux surgery ad modum Watson

Laparoscopic anterior fundoplication

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age:18-65 years.
* Good results of PPI treatment (\<3 months) resulting in reduced heart burn and acid regurgitations.
* Gastroesophageal reflux disease as evidence by gastroscopy and pH-monitoring.

Exclusion Criteria

* Previous surgery on the stomach
* Patients with IBS (criteria ROM II)
* Severe disease, for example diabetes mellitus, cardiopulmonary disease or renal disease, that would influence outcome measurement
* Patients with active ulcer disease
* Paraesophageal hernia
* Patient that are incapable to understand the study information (for example mentally disorder, drug abuse)
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Region Skane

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pauline Djerf, Md

Role: PRINCIPAL_INVESTIGATOR

Region Skane

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Surgery

Kalmar, , Sweden

Site Status

Department of Surgery

Lund, , Sweden

Site Status

Department of Surgery

Malmo, , Sweden

Site Status

Department of Surgery

Trollhättan, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NW20012011

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

LINX vs Fundoplication
NCT07093359 RECRUITING PHASE3